Twinomujuni Silvano S, Oloro Joseph, Alele Paul E
Department of Pharmacy, Mbarara University of Science and Technology, Uganda.
Department of Pharmacology and Therapeutics, Mbarara University of Science and Technology, Uganda.
Afr J Pharm Pharmacol. 2016 Mar;10(12):216-222. doi: 10.5897/AJPP2015.4488.
Modern drug therapy of epilepsy is complicated by the inability of drugs to control seizures in some patients and side effects that range in severity from minimal impairment of the central nervous system to death from aplastic anemia or hepatic failure. Medicinal plants used in traditional medicine for the treatment of epilepsy have been scientifically shown to possess promising anticonvulsant activities in animal models for screening for anticonvulsant activity and can be a source of newer anticonvulsants. The aim of this study was to investigate the preliminary phytochemical properties, anticonvulsant and anxiolytic activities of aqueous and ethanolic extracts. Phytochemicals from the aqueous and ethanolic extracts were screened by standard methods. Anticonvulsant activity was evaluated against pentylenetetrazol (PTZ)-induced seizure model in rats. The effect of the extract at oral dose levels of 250, 500 and 1000 mg/kg was evaluated in an experimental rat model, using diazepam (5 mg/kg) as positive control. Anxiolytic activity was performed using elevated plus maze method. Phytochemical screening revealed that extracts contain carbohydrates, flavonoids, saponins, glycosides, tannins, terpenoids, phenols and phytosterols. The aqueous extract at a dose of 500 mg/kg significantly increased seizure latency (P=0.0023), while the ethanolic extract did not have a significant effect on seizure latency. Both extracts significantly reduced the seizure severity (P= 0.0155), and provided up to 100% protection against PTZ induced death at 1000 mg/kg. Both extracts had no significant effect on the duration of PTZ induced seizures. Both extracts were found to increase the number of entries and the time spent in the open arms of the maze at a dose of 250 mg/kg, indicating anxiolytic activity, which was not seen at higher doses (500 and 1000 mg/kg). The total numbers of entries into the closed arm were significantly reduced at 500 and 1000 mg/kg oral doses of both extracts, indicating a reduction in locomotor activity of the rats. The results obtained in this study suggest that both the aqueous and ethanolic extracts of possess anticonvulsant and anxiolytic activities in a rat model.
现代癫痫药物治疗存在一些问题,某些患者使用药物无法控制癫痫发作,且副作用严重程度不一,从对中枢神经系统的轻微损害到再生障碍性贫血或肝衰竭导致的死亡。传统医学中用于治疗癫痫的药用植物经科学证明在动物模型中具有有前景的抗惊厥活性,可用于筛选抗惊厥活性,并且可能成为新型抗惊厥药物的来源。本研究的目的是调查水提取物和乙醇提取物的初步植物化学性质、抗惊厥和抗焦虑活性。通过标准方法对水提取物和乙醇提取物中的植物化学物质进行筛选。针对大鼠戊四氮(PTZ)诱导的癫痫发作模型评估抗惊厥活性。在实验大鼠模型中评估提取物在250、500和1000 mg/kg口服剂量水平的效果,使用地西泮(5 mg/kg)作为阳性对照。采用高架十字迷宫法进行抗焦虑活性研究。植物化学筛选显示提取物含有碳水化合物、黄酮类、皂苷、糖苷、单宁、萜类、酚类和植物甾醇。500 mg/kg剂量的水提取物显著增加癫痫发作潜伏期(P = 0.0023),而乙醇提取物对癫痫发作潜伏期没有显著影响。两种提取物均显著降低癫痫发作严重程度(P = 0.0155),并且在1000 mg/kg时对PTZ诱导的死亡提供高达100%的保护。两种提取物对PTZ诱导的癫痫发作持续时间均无显著影响。发现两种提取物在250 mg/kg剂量时可增加进入迷宫开放臂的次数和在开放臂中停留的时间,表明具有抗焦虑活性,在较高剂量(500和1000 mg/kg)时未观察到这种活性。两种提取物在500和1000 mg/kg口服剂量时进入封闭臂的总次数显著减少,表明大鼠的运动活动减少。本研究获得的结果表明,该植物的水提取物和乙醇提取物在大鼠模型中均具有抗惊厥和抗焦虑活性。